DEC 07, 2021 7:00 AM PST

Do Your Antibodies Protect Against Omicron? Rapid Test Delivers Answers in Minutes.

WRITTEN BY: Tara Fernandes

More mutations, more transmissible, and more likely to infect vaccinated people—coronavirus variants such as Omicron have once again put the globe on high alert. 

"It's one of the lingering fears that, as we successfully vaccinate more and more people, a variant may emerge that more radically evades vaccine-induced antibody neutralization," said Duke University's Cameron Wolfe. Wolfe is a biomedical engineer pioneering a new technology that can rapidly measure whether an individual has sufficient immune protection to fend off these "variants of concern."

We are in a particularly vulnerable position with no reliable way of testing whether a vaccinated person has an elevated risk of becoming infected. 

In their study, featured in the journal Science Advances, the team describes the mechanism behind COVID-19 Variant Spike-ACE2-Competitive Antibody Neutralization assay or CoVariant-SCAN. Among the key benefits of the test is that it's incredibly sensitive—an array of 'molecular traps' catch even trace amounts of viral antigens within a sample.

The 'bait' used in the traps is a fluorescent human ACE2 protein. This is the receptor on respiratory cells that the coronavirus uses as a gateway into the human body. Also on the device are replicas of spike proteins from each coronavirus variant. During the test, the glowing ACE2 proteins are dislodged and flow over the surface of the spike proteins. When they attach, it causes the well to emit fluorescence that is measured.

However, if the patient sample contains neutralizing antibodies, these proteins block the ACE2-spike interaction, and the slide remains dark. By including an array of spike protein variants, the test quickly assesses how robust a person's immune system is at protecting them from these new threats.

Current methods for retrieving such data use a long, multi-step process involving live virus and cell culture systems that have to be performed by specialized operators. CoVariant-SCAN, on the other hand, is easy to use and takes just 15 minutes to generate a result.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
FEB 03, 2022
Cannabis Sciences
A Standard THC Unit: Standardizing Dosage in Cannabis Industry & Research
FEB 03, 2022
A Standard THC Unit: Standardizing Dosage in Cannabis Industry & Research
A primary limitation of cannabis research thus far has been the inconsistent quantification of exposure to the plant&rsq ...
APR 19, 2022
Cardiology
Daily Coffee May Improve Longevity and Heart Health
APR 19, 2022
Daily Coffee May Improve Longevity and Heart Health
Good news for coffee fans!
APR 22, 2022
Genetics & Genomics
Identifying "Cancer Culprits" in the Genome
APR 22, 2022
Identifying "Cancer Culprits" in the Genome
Most cells carry the complete genome in their nucleus, and as cells divide and age, they can pick up mutations in that g ...
APR 27, 2022
Clinical & Molecular DX
Asthma Risk Increased in Children Conceived with Infertility Treatment
APR 27, 2022
Asthma Risk Increased in Children Conceived with Infertility Treatment
Asthma is a disease characterized by difficulty breathing, and an asthma attack can bring on bouts of coughing and wheez ...
MAY 13, 2022
Drug Discovery & Development
Multiple Mental Health Diagnoses are Increasingly Common. Why?
MAY 13, 2022
Multiple Mental Health Diagnoses are Increasingly Common. Why?
Mental illness has become increasingly common. The number of people with anxiety and depression, specifically, has stead ...
MAY 16, 2022
Genetics & Genomics
Sarin Gas Revealed as Cause of Gulf War Syndrome
MAY 16, 2022
Sarin Gas Revealed as Cause of Gulf War Syndrome
Gulf War illness (GWI) is an umbrella term that describes an array of chronic symptoms that have impacted an estimated 2 ...
Loading Comments...